384 related articles for article (PubMed ID: 28709825)
1. The Ambiguous Role of γδ T Lymphocytes in Antitumor Immunity.
Chitadze G; Oberg HH; Wesch D; Kabelitz D
Trends Immunol; 2017 Sep; 38(9):668-678. PubMed ID: 28709825
[TBL] [Abstract][Full Text] [Related]
2. γδ T cell-based anticancer immunotherapy: progress and possibilities.
Meraviglia S; Lo Presti E; Dieli F; Stassi G
Immunotherapy; 2015; 7(9):949-51. PubMed ID: 26569071
[No Abstract] [Full Text] [Related]
3. γδ T cells in cancer immunotherapy.
Zou C; Zhao P; Xiao Z; Han X; Fu F; Fu L
Oncotarget; 2017 Jan; 8(5):8900-8909. PubMed ID: 27823972
[TBL] [Abstract][Full Text] [Related]
4. Cancer immunotherapy with γδ T cells: many paths ahead of us.
Kabelitz D; Serrano R; Kouakanou L; Peters C; Kalyan S
Cell Mol Immunol; 2020 Sep; 17(9):925-939. PubMed ID: 32699351
[TBL] [Abstract][Full Text] [Related]
5. Harnessing the power of Vδ2 cells in cancer immunotherapy.
Fowler DW; Bodman-Smith MD
Clin Exp Immunol; 2015 Apr; 180(1):1-10. PubMed ID: 25469879
[TBL] [Abstract][Full Text] [Related]
6. Regulatory and effector functions of gamma-delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer.
Paul S; Lal G
Int J Cancer; 2016 Sep; 139(5):976-85. PubMed ID: 27012367
[TBL] [Abstract][Full Text] [Related]
7. The emerging Protumor role of γδ T lymphocytes: implications for cancer immunotherapy.
Rei M; Pennington DJ; Silva-Santos B
Cancer Res; 2015 Mar; 75(5):798-802. PubMed ID: 25660949
[TBL] [Abstract][Full Text] [Related]
8. Strategies to Improve the Antitumor Effect of γδ T Cell Immunotherapy for Clinical Application.
Miyashita M; Shimizu T; Ashihara E; Ukimura O
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445615
[TBL] [Abstract][Full Text] [Related]
9. The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy.
Legut M; Cole DK; Sewell AK
Cell Mol Immunol; 2015 Nov; 12(6):656-68. PubMed ID: 25864915
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside.
Braza MS; Klein B
Br J Haematol; 2013 Jan; 160(2):123-32. PubMed ID: 23061882
[TBL] [Abstract][Full Text] [Related]
11. Expression of intercellular adhesion molecule (ICAM)-1 or ICAM-2 is critical in determining sensitivity of pancreatic cancer cells to cytolysis by human gammadelta-T cells: implications in the design of gammadelta-T-cell-based immunotherapies for pancreatic cancer.
Liu Z; Guo B; Lopez RD
J Gastroenterol Hepatol; 2009 May; 24(5):900-11. PubMed ID: 19175829
[TBL] [Abstract][Full Text] [Related]
12. γδ cells and tumor microenvironment: A helpful or a dangerous liason?
Lo Presti E; Di Mitri R; Pizzolato G; Mocciaro F; Dieli F; Meraviglia S
J Leukoc Biol; 2018 Mar; 103(3):485-492. PubMed ID: 29345336
[TBL] [Abstract][Full Text] [Related]
13. Harnessing γδ T cells in anticancer immunotherapy.
Hannani D; Ma Y; Yamazaki T; Déchanet-Merville J; Kroemer G; Zitvogel L
Trends Immunol; 2012 May; 33(5):199-206. PubMed ID: 22364810
[TBL] [Abstract][Full Text] [Related]
14. The subtle interplay between gamma delta T lymphocytes and dendritic cells: is there a role for a therapeutic cancer vaccine in the era of combinatorial strategies?
Galati D; Zanotta S; Bocchino M; De Filippi R; Pinto A
Cancer Immunol Immunother; 2021 Jul; 70(7):1797-1809. PubMed ID: 33386466
[TBL] [Abstract][Full Text] [Related]
15. γδ T cells in cancer.
Silva-Santos B; Serre K; Norell H
Nat Rev Immunol; 2015 Nov; 15(11):683-91. PubMed ID: 26449179
[TBL] [Abstract][Full Text] [Related]
16. The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy.
Liu Y; Zhang C
Cells; 2020 May; 9(5):. PubMed ID: 32413966
[TBL] [Abstract][Full Text] [Related]
17. Prospects for immunotherapy of acute myeloid leukemia using γδ T cells.
Halim L; Parente-Pereira AC; Maher J
Immunotherapy; 2017 Jan; 9(2):111-114. PubMed ID: 28128710
[No Abstract] [Full Text] [Related]
18. γδ T cells and the PD-1/PD-L1 axis: a love-hate relationship in the tumor microenvironment.
Liu J; Wu M; Yang Y; Wang Z; He S; Tian X; Wang H
J Transl Med; 2024 Jun; 22(1):553. PubMed ID: 38858763
[TBL] [Abstract][Full Text] [Related]
19. Myeloid molecular characteristics of human γδ T cells support their acquisition of tumor antigen-presenting capacity.
Muto M; Baghdadi M; Maekawa R; Wada H; Seino K
Cancer Immunol Immunother; 2015 Aug; 64(8):941-9. PubMed ID: 25904200
[TBL] [Abstract][Full Text] [Related]
20. Pro-tumor γδ T Cells in Human Cancer: Polarization, Mechanisms of Action, and Implications for Therapy.
Chabab G; Barjon C; Bonnefoy N; Lafont V
Front Immunol; 2020; 11():2186. PubMed ID: 33042132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
